Minocycline infusion sclerotherapy for infected hepatic cysts in a patient with autosomal dominant polycystic kidney disease: a case report and literature review

米诺环素灌注硬化疗法治疗常染色体显性多囊肾病患者感染性肝囊肿:病例报告及文献综述

阅读:1

Abstract

We report the case of a Japanese man in his 60 s undergoing hemodialysis for end-stage renal disease due to autosomal dominant polycystic kidney disease, who had experienced repeated hepatic cyst infections. Despite treatment with oral antibiotics, including minocycline and trimethoprim-sulfamethoxazole, he presented with fever and was admitted to our hospital. Diffusion-weighted magnetic resonance imaging demonstrated a high signal intensity in a large hepatic cyst, and percutaneous transhepatic drainage was performed. Enterococcus faecium was isolated from the cyst fluid. Three intracystic minocycline infusions were administered in combination with intravenous vancomycin after dialysis. The patient achieved clinical improvement and remained free from recurrence until day 253 of illness. Infections in large cysts tend to be refractory, and drainage alone may be insufficient, particularly in immunocompromised patients on hemodialysis. Intracystic sclerotherapy with minocycline offers both antimicrobial and sclerosing effects, with previous reports demonstrating cyst shrinkage and infection control in non-dialysis patients. To our knowledge, this is the first report describing successful intracystic minocycline infusion in a patient undergoing hemodialysis, and no recurrence or significant adverse events were observed. Intracystic minocycline infusion sclerotherapy may be a safe and effective therapeutic option for hepatic cyst infection in this population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。